Skip to main content
Log in

A rat model of distractibility: effects of drugs modifying dopaminergic, noradrenergic and GABA ergic neurotransmission

  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Summary

A procedure for analyzing effects of drugs on distractibility is proposed. Rats are trained to traverse a straight runway with a sucrose solution as reinforcement. Once the response has been acquired, an additional runway ending in an empty box is connected. The time spent investigating this additional runway is the measure of distractibility. Amphetamine, 1 mg/kg i.p., increased distractibility. In rats that were never reinforced, amphetamine at a dose of 1 mg/kg reduced the time spent in the additional runway. This shows that the effects of amphetamine in the reinforced animals cannot be interpreted as enhanced exploration. Furthermore, the benzodiazepines diazepam (2 and 4 mg/kg, i.p.) and chlordiazepoxide (2.5, 5 and 10 mg/kg, i.p.), known to enhance exploration of novel environments, did not affect the time spent in the additional runway in sucrose-reinforced animals. It was concluded that the procedure indeed is a model of distractibility. The dopamine antagonist cis(Z)-flupenthixol, at a dose of 0.25 mg/kg, i.p., blocked the effects of amphetamine, 1 mg/kg. Flupenthixol itself, in doses of 0.25 and 0.5 mg/kg, did not affect the time spent in the additional runway. This suggests that enhanced dopaminergic activity indeed is responsible for the effects. This proposal is further supported by experiments showing that the noradrenaline precursor dihydroxyphenylserine (10 mg/kg + carbidopa, 50 mg/kg, both i.p.) and the noradrenergic neurotoxin DSP4 (50 mg/kg, i.p.) had no effect on distractibility. Moreover, amfonelic acid, a dopamine releaser with slight or no effect on noradrenergic neurotransmission, had effects very similar to those of amphetamine when given in doses of 0.25 and 0.5 mg/kg, i.p. A lower dose, 0.125 mg/ kg, was ineffective. Taken together, these data suggest that enhanced dopaminergic neurotransmission increases distractibility in the rat. However, both amphetamine and amfonelic acid may stimulate serotonin release. Until serotonergic drugs have been tested, a contribution of this transmitter cannot be ruled out. The distraction procedure may constitute an animal model of some kinds of disordered information processing.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Ågmo A, Fernández H (1989) Dopamine and sexual behavior in the male rat: a reevaluation. J Neural Transm 77: 21–37

    PubMed  Google Scholar 

  • Ågmo A, Picker Z (1990) Catecholamines and the initiation of sexual behavior in male rats without sexual experience. Pharmacol Biochem Behav 35: 327–334

    PubMed  Google Scholar 

  • Ågmo A, Fernández H (1991) Benzodiazepine receptor ligands and sexual behavior in the male rat: the role of GABAergic mechanisms. Pharmacol Biochem Behav 38: 781–788

    PubMed  Google Scholar 

  • Ågmo A, Pruneda R, Guzmán M, Gutièrrez M (1991) GABAergic drugs and conflict behavior in the rat: lack of similarities with the actions of benzodiazepines. Naunyn Schmiedebergs Arch Pharmacol 344: 314–322

    PubMed  Google Scholar 

  • Ågmo A, Galvan A, Talamantes B (1995) Reward and reinforcement produced by drinking sucrose: two processes that may depend on different neurotransmitters. Pharmacol Biochem Behav 52: 403–414

    PubMed  Google Scholar 

  • Braff DL (1993) Information processing and attention dysfunctions in schizophrenia. Schizophr Bull 19: 233–259

    PubMed  Google Scholar 

  • Cohen BM, Lipinski FH (1986) In vivo potencies of antispychotic drugs in blocking alpha1 noradrenergic and dopamine D2 receptors: implications for drug mechanisms of action. Life Sci 39: 2571–2580

    PubMed  Google Scholar 

  • Crider A, Solomon PR, McMahon MA (1982) Disruption of selective attention in the rat following chronic d-amphetamine administration: relationship to schizophrenic attention disorder. Biol Psychiat 17: 351–361

    PubMed  Google Scholar 

  • Crider A, Blockel L, Solomon PR (1986) A selective attention deficit in the rat following induced dopamine receptor supersensitivity. Behav Neurosci 100: 315–319

    PubMed  Google Scholar 

  • Dunn LA, Atwater GE, Kilts CD (1993) Effects of antipsychotic drugs on latent inhibition: sensitivity and specificity of an animal behavioral model of clinical drug action. Psychopharmacology 112: 315–323

    PubMed  Google Scholar 

  • Edwards DJ, Sedlock ML (1982) Increased brain concentration of homovanillic acid in rats treated with threo-3,4-dihydroxyphenylserine. J Pharm Pharmacol 34: 685–686

    PubMed  Google Scholar 

  • Ellenbroek BA, Cools AR (1990) Animal models with construct validity for schizophrenia. Behav Pharmacol 1: 469–490

    PubMed  Google Scholar 

  • Feldon J, Weiner I (1989) Abolition of the acquisition but not the expression of latent inhibition by chlordiazepoxide in rats. Pharmacol Biochem Behav 32: 123–127

    PubMed  Google Scholar 

  • Feldon J, Weiner I (1991) The latent inhibition model of schizophrenic attention disorder: haloperidol and sulpiride enhance rats' ability to ignore irrelevant stimuli. Biol Psychiat 29: 636–646

    Google Scholar 

  • Feldon J, Shofel A, Weiner I (1991) Latent inhibition is unaffected by direct acting dopamine agonists. Pharmacol Biochem Behav 38: 309–314

    PubMed  Google Scholar 

  • Franke P, Maier W, Hardt J, Hain C, Cornblatt BA (1994) Attentional abilities and measures of schizotypy: their variation and covariation in schizophrenic patients, their siblings, and normal control subjects. Psychiat Res 54: 259–272

    Google Scholar 

  • Gray JA, Feldon J, Rawlins JNP, Hemsley DR, Smith AD (1991) The neuropsychology of schizophrenia. Behav Brain Sci 14: 1–84

    Google Scholar 

  • Harvey P, Peddley M (1989) Auditory and visual distractibility in schizophrenia. Schizophr Res 2: 295–300

    PubMed  Google Scholar 

  • Hemsley DR (1987) An experimental psychological model for schizophrenia. In: Häfner H, Gattaz WF, Janzarik W (eds) Search for the causes of schizophrenia. Springer, Berlin Heidelberg New York Tokyo, pp 179–188

    Google Scholar 

  • Honey RC, Hall G (1989) Attenuation of latent inhibition after compound pre-exposure: associative and perceptual explanations. Q J Exp Psych Sect B Comp Physiol Psychol 41: 355–368

    Google Scholar 

  • Hughes RN, Greig AM (1976) Effects of caffeine, methamphetamine and methylphenidate on reactions to novelty and activity in rats. Neuropharmacology 15: 673–676

    PubMed  Google Scholar 

  • Hyttel J (1983) SCH 23390 — The first selective dopamine D-1 antagonist. Eur J Pharmacol 91: 153–154

    PubMed  Google Scholar 

  • Joseph MH, Jones SH (1991) Latent inhibition and blocking: further considerations of their construct validity as animal models of schizophrenia. Behav Pharmacol 2: 521–526

    PubMed  Google Scholar 

  • Kamin LJ (1968) “Attention-like” processes in classical conditioning. In: Jones MR (ed) Miami symposium on the prediction of behavior. University of Miami Press, Coral Gables FL, pp 9–33

    Google Scholar 

  • Killcross AS, Robbins TW (1993) Differential effects of intra-accumbens and systemic amphetamine on latent inhibition using an on-baseline, within-subject conditioned suppression paradigm. Psychopharmacology 110: 479–489

    PubMed  Google Scholar 

  • Kumar R (1969) Exploration and latent learning: differential effects of dexamphetamine on components of exploratory behaviour in rats. Psychopharmacologia 16: 54–72

    PubMed  Google Scholar 

  • Kumar R (1971) Extinction of fear. I. Effects of amylobarbitone and dexamphetamine given separately and in combination on fear and exploratory behaviour in rats. Psychopharmacologia 19: 163–187

    PubMed  Google Scholar 

  • Kuczenski R, Segal DS (1994) Neurochemistry of amphetamine. In: Cho A, Segal DS (eds) Amphetamine and its analogs: psychopharmacology, toxicology and abuse. Academic Press, New York, pp 81–113

    Google Scholar 

  • Lister RG (1990) Ethologically based animal models of anxiety disorders. Pharmacol Ther 46: 321–340

    PubMed  Google Scholar 

  • Lubow RE, Moore AU (1959) Latent inhibition. The effect of non-reinforced preexposure to the conditioned stimulus. J Comp Physiol Psychol 52: 415–419

    PubMed  Google Scholar 

  • Matsubara S, Matsubara R, Kusumi I, Koyama T, Yamashita I (1993) Dopamine D1 D2 and serotonin2 receptor occupation by typical and atypical antipsychotic drugs in vivo. J Pharmacol Exp Ther 265: 498–508

    PubMed  Google Scholar 

  • McGaugh JL (1989) Dissociating learning and performance: drug and hormone enhancement of memory storage. Brain Res Bull 23: 339–345

    PubMed  Google Scholar 

  • Misslin R, Ropartz P (1981) Effects of metamphetamine on novelty-seeking behaviour in mice. Psychopharmacology 75: 39–43

    PubMed  Google Scholar 

  • Paredes RG, Ågmo A (1992) GABA and behavior: the role of receptor subtypes. Neurosci Biobehav Rev 16: 145–170

    PubMed  Google Scholar 

  • Peroutka SJ, U'Prichard DC, Greenberg DA, Snyder SH (1977) Neuroleptic drag interactions with norepinephrine alpha receptor binding sites in rat brain. Neuropharmacology 16: 549–556

    PubMed  Google Scholar 

  • Reches A, Jackson-Lewis V, Fahn S (1985) Dl-threo-DOPS as a precursor of noradrenaline. Naunyn Schmiedebergs Arch Pharmacol 331: 202–208

    PubMed  Google Scholar 

  • Robbins T, Iversen SD (1973) A dissociation of the effects of d-amphetamine on locomotor activity and exploration in rats. Psychopharmacologia 28: 155–164

    PubMed  Google Scholar 

  • Russell PA (1983) Psychological studies of exploration in animals: a reappraisal. In: Archer J, Birke L (eds) Exploration in animals and humans. Van Nostrand Reinhold, London, pp 22–54

    Google Scholar 

  • Solomon PR, Staton DM (1982) Differential effects of microinjections of d-amphetamine into the nucleus accumbens or the caudate putamen on the rat's ability to ignore irrelevant stimulus. Biol Psychiat 17: 743–756

    PubMed  Google Scholar 

  • Speciale Jr SG, Karoum F, Wyatt RJ (1980) Different effects of amphetamine and amfonelic acid on peripheral and central catecholamine metabolism. Eur J Pharmacol 62: 297–307

    PubMed  Google Scholar 

  • Strupp BJ, Bunsey M, Levtsky D, Kesler M (1991) Time-dependent effects of post-trial amphetamine treatment in rats: evidence for enhanced storage of representational memory. Behav Neural Biol 56: 62–76

    PubMed  Google Scholar 

  • Tombaugh TN, Tombaugh J, Anisman H (1979) Effects of dopamine receptor blockade on alimentary behaviors: home cage food consumption, operant acquisition and performance. Psychopharmacology 66: 219–225

    PubMed  Google Scholar 

  • Warburton EC, Feldon J, Weiner I, Gray JA, Joseph MH (1992) Antagonism of low dose amphetamine disruption of latent inhibition in rats by haloperidol, and by the 5-HT3 antagonist, ondansetron. J Psychopharmacol 6: 110

    Google Scholar 

  • Weiner I (1990) Neural substrates of latent inhibition: the switching model. Psychol Bull 108: 442–461

    PubMed  Google Scholar 

  • Weiner I, Lubow RE, Feldon J (1981) Chronic amphetamine and latent inhibition. Behav Brain Res 2: 285–286

    Google Scholar 

  • Weiner I, Lubow RE, Feldon J (1984) Abolition of the expression but not the acquisition of latent inhibition by chronic amphetamine in rats. Psychopharmacology 83: 194–199

    PubMed  Google Scholar 

  • Weiner I, Lubow RE, Feldon J (1988) Disruption of latent inhibition by acute administration of low doses of amphetamine. Pharmacol Biochem Behav 30: 871–878

    PubMed  Google Scholar 

  • Wise RA, Colle LA (1984) Pimozide attenuates free feeding: best scores analysis reveals a motivational deficit. Psychopharmacology 84: 446–451

    PubMed  Google Scholar 

  • Wurtman RJ, Watkins CJ (1977) Suppression of noradrenaline synthesis in sympathetic nerves by carbidopa, an inhibitor of peripheral dopa decarboxylase. Nature 265: 79–80

    PubMed  Google Scholar 

  • Young PT (1959) The role of affective processes in learning and motivation. Psychol Rev 66: 104–125

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Parts of these data were presented at the Annual Meeting of the Mexican Physiological Society, Querétaro, Mexico, August 14–18, 1988, and at the Second International Behavioral Neuroscience Conference, Clearwater, FL, April 23–25, 1993

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ågmo, A., Belzung, C. & Rodríguez, C. A rat model of distractibility: effects of drugs modifying dopaminergic, noradrenergic and GABA ergic neurotransmission. J. Neural Transmission 104, 11–29 (1997). https://doi.org/10.1007/BF01271291

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01271291

Keywords

Navigation